NDC 50268-042 Acetazolamide Extended-release
Capsule Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 50268 - Avpak
- 50268-042 - Acetazolamide Extended-release
Product Characteristics
Product Packages
NDC Code 50268-042-12
Package Description: 20 BLISTER PACK in 1 BOX / 1 CAPSULE in 1 BLISTER PACK (50268-042-11)
Price per Unit: $0.32800 per EA
Product Details
What is NDC 50268-042?
What are the uses for Acetazolamide Extended-release?
What are Acetazolamide Extended-release Active Ingredients?
- ACETAZOLAMIDE 500 mg/1 - One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Which are Acetazolamide Extended-release UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAZOLAMIDE (UNII: O3FX965V0I)
- ACETAZOLAMIDE (UNII: O3FX965V0I) (Active Moiety)
Which are Acetazolamide Extended-release Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- TALC (UNII: 7SEV7J4R1U)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- D&C RED NO. 28 (UNII: 767IP0Y5NH)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- GELATIN (UNII: 2G86QN327L)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- SHELLAC (UNII: 46N107B71O)
- ALCOHOL (UNII: 3K9958V90M)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- AMMONIA (UNII: 5138Q19F1X)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
What is the NDC to RxNorm Crosswalk for Acetazolamide Extended-release?
- RxCUI: 562524 - acetaZOLAMIDE 500 MG 12HR Extended Release Oral Capsule
- RxCUI: 562524 - 12 HR acetazolamide 500 MG Extended Release Oral Capsule
- RxCUI: 562524 - acetazolamide 500 MG 12 HR Extended Release Oral Capsule
Which are the Pharmacologic Classes for Acetazolamide Extended-release?
* Please review the disclaimer below.
Patient Education
Acetazolamide
Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye. Acetazolamide is also used to reduce the severity and duration of symptoms (upset stomach, headache, shortness of breath, dizziness, drowsiness, and fatigue) of altitude (mountain) sickness. Acetazolamide is used with other medicines to reduce edema (excess fluid retention) and to help control seizures in certain types of epilepsy. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".